Investigation of Cytotoxic T-lymphocyte antigen-4 polymorphisms in non-small cell lung cancer: A case-control study

Abstract

The objective of this case-control study was to extensively explore the relationship of Cytotoxic T-lymphocyte antigen-4 (CTLA-4) tagging polymorphisms with susceptibility to non-small-cell lung cancer (NSCLC). We recruited 521 sporadic NSCLC cases and 1,030 non-cancer controls. The genotypes of CTLA-4 rs16840252 C > T, rs231775 G > A, rs3087243 G > A and rs733618 T > C polymorphisms were evaluated using a custom-by-design 48-Plex SNPscan Kit. Our findings revealed there was no statistically significant difference in CTLA-4 genotypes distribution among NSCLC patients and non-cancer controls. Similar findings were observed in the logistic regression analyses. However, the stratified analyses suggested CTLA-4 rs733618 vatiants were correlated with the development of NSCLC in = 60 years subgroup (TC vs. TT: adjusted OR = 1.45, 95% CI = 1.04-2.02, P = 0.030) and even drinking subgroup (TC vs. TT: adjusted OR = 2.27, 95% CI = 1.11-4.60, P = 0.024 and TC/CC vs. TT: adjusted OR = 2.26, 95% CI = 1.15-4.43, P = 0.018). In conclusion, the present case-control study highlights that the CTLA-4 rs733618 T > C polymorphism was associated with the development of NSCLC in = 60 years and even drinking subgroups. A fine-mapping study with functional assessment is necessary to confirm or refute our findings.